Patients with diabetes need to be examined at least annually. The reason is to be on the look out for the development of diabetic retinopathy. That’s […]
A five year prospective study reveals that insulin glargine is as safe as NPH insulin with regard to developing diabetic retinopathy. Patients placed on insulin glargine […]